logo

Enter Symbol
Overview
Community Research
Company Profile
Technical Charts
Analyst Ratings
Analyst Estimates
 
Sales Estimates
 
Related News
 
Blog Articles
 
Press Releases
 
Technicals
 

FORTICELL(OTC:FORB)
# Employees: 20
Address: 3960 Broadway,New York,,USA
Phone: 212 740-6999
Fax: 212-740-2570
Website: www.forticellbioscience.com
Email: ir@forticellbioscience.com
Sector: Medical
Industry: MED-BIOMED/GENE
Executive Officers
Steven Katz Ph.D. (Chmn.)
Steven Lilien Ph.D. (Dir.)
Alan W. Schoenbart (C.F.O.)
Ron Lipstein (Vice-Chmn.; C.E.O.; Sec.; Treas.)
Costantin Papastephanou Ph.D. (Presi.; C.O.O.,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 6/30/2001
Next Earnings Date(Expected): 1/1/1990
Mean EPS (Next Qtr): ($0.01)
Mean EPS (Year): ($0.01)
Mean Estimate(Long Term): ($0.01)
P/E Ratio(Based on EPS estimate): -0.010
Number of Estimates: 0
Shares Performance
Period FORB Compare to S&P
YTD -97.37 % -85.99 %
4 Weeks -83.33 % -83.39 %
12 Weeks -87.50 % -81.18 %
Shares Information
Analyst Coverage: N
Avg Volume: 5157
Shares Outstanding: 13M
Market Cap: $0.00B
52 Week High: $0.59
52 Week Low: $0.01
P/E Ratio: -0.010
PEG Ratio: -0.010
Split: On 7/25/2006 FORB split by factor of 0.070
Earnings Performance
EPS Growth in Last Quarter: -50.00 %
EPS Growth in Last Year: -0.01 %
Sales Growth in Last Quarter: -0.01 %
Sales Growth in Last Quarter: -0.01 %
Financials
Qtr Book Value: ($0.01)
Cash Flow/Share: $0.01
Change in Payout Ratio: -0.010
Price/Sales: -0.010
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia